Trial Profile
Serum PAI-1 levels in type 2 diabetic patients on sitagliptin treatment.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Jun 2012
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 03 Jun 2012 Actual end date (Mar 2012) added as reported by University Hospital Medical Information Network - Japan.
- 03 Jun 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 03 Jun 2011 Planned end date (1 Oct 2010) added according to University Hospital Medical Information Network - Japan.